Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Pride 2024: How can pharma leaders make a difference?
Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.
Read more
5 minutes with Anat Cohen-Dayag, CEO, Compugen
Five minutes with Anat Cohen-Dayag, CEO of clinical-stage drug discovery and development company Compugen.
Is the biotech boom on thin ice?
After dizzying heights of investment during the pandemic, biotechs have observed a slump, but the future may look more promising.
Artificially intelligent drug discovery
AI is being implemented into drug development to free up time, money and manpower, but how can humans and computers work together?
Embracing pharma's digital transformation
In his first regular column for GOLD, Davidek Herron discusses digital transformation in pharma and pursuing operational excellence.
An opportunity to crack the opioid crisis
With opioid abuse showing little sign of abating, what role can pharma play in addressing the crisis?
Pharma in Kenya
Kenya is home to a budding pharma sector, but the country still faces access to medicine challenges. What are they, and how can pharma help?
Roundtable: a discussion on the pandemic and gender parity
Hear from two industry thought leaders to find out how the pharmaceutical industry is harnessing the COVID-19 to advance rather than derail their mission to improve female representation.
A roundtable on clinical trial transformation
Clinical trials of the past struggled with patient enrolment and cost efficiency. What can the pharmaceutical industry learn to improve them?
Loading posts...
« Previous
1
…
9
10
11
12
13
…
30
Next »